PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells

Nucleic Acids Research

Volumn 41, Issue 8, 2013, Pages 4447-4458

  Chang, Fiona T M ^a   McGhie, James D ^a   Chan, F Lyn ^a   Tang, Michelle C ^b   Anderson, Melissa A ^b   Mann, Jeffrey R ^b   Andy Choo, K H ^b   Wong, Lee H ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA X MENTAL RETARDATION PROTEIN; CHAPERONE; DEATH DOMAIN ASSOCIATED PROTEIN; DNA; HISTONE H3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA BODY; PROTEIN BINDING; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TELOMERE;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS STRUCTURES; CHROMATIN; DNA HELICASES; DNA REPAIR; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HISTONES; HUMANS; MICE; NIH 3T3 CELLS; NUCLEAR PROTEINS; PHENOTYPE; S PHASE; TELOMERE;

EID: 84877283370     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt114     Document Type: Article

References (56)

1. Costa, A., Daidone, M.G., Daprai, L., Villa, R., Cantu, S., Pilotti, S., Mariani, L., Gronchi, A., Henson, J.D., Reddel, R.R. et al. (2006) Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res., 66, 8918-8924.
2. Hakin-Smith, V., Jellinek, D.A., Levy, D., Carroll, T., Teo, M., Timperley, W.R., McKay, M.J., Reddel, R.R. and Royds, J.A. (2003) Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet, 361, 836-838.
3. Dunham, M.A., Neumann, A.A., Fasching, C.L. and Reddel, R.R. (2000) Telomere maintenance by recombination in human cells. Nat. Genet., 26, 447-450.
4. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A. and Reddel, R.R. (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med., 3, 1271-1274.
5. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. and Reddel, R.R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J., 14, 4240-4248.
6. Henson, J.D., Hannay, J.A., McCarthy, S.W., Royds, J.A., Yeager, T.R., Robinson, R.A., Wharton, S.B., Jellinek, D.A., Arbuckle, S.M., Yoo, J. et al. (2005) A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin. Cancer Res., 11, 217-225.
7. Henson, J.D., Cao, Y., Huschtscha, L.I., Chang, A.C., Au, A.Y., Pickett, H.A. and Reddel, R.R. (2009) DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat. Biotechnol., 27, 1181-1185.
8. Cesare, A.J. and Reddel, R.R. (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet., 11, 319-330.
9. Garcia-Cao, M., O'Sullivan, R., Peters, A.H., Jenuwein, T. and Blasco, M.A. (2004) Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet., 36, 94-99.
10. Gonzalo, S., Jaco, I., Fraga, M.F., Chen, T., Li, E., Esteller, M. and Blasco, M.A. (2006) DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol., 8, 416-424.
11. Benetti, R., Gonzalo, S., Jaco, I., Schotta, G., Klatt, P., Jenuwein, T. and Blasco, M.A. (2007) Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol., 178, 925-936.
12. Wong, L.H., McGhie, J.D., Sim, M., Anderson, M.A., Ahn, S., Hannan, R.D., George, A.J., Morgan, K.A., Mann, J.R. and Choo, K.H. (2010) ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res., 20, 351-360.
13. Wong, L.H., Ren, H., Williams, E., McGhie, J., Ahn, S., Sim, M., Tam, A., Earle, E., Anderson, M.A., Mann, J. et al. (2009) Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res., 19, 404-414.
14. Marion, R.M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M. and Blasco, M.A. (2009) Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell, 4, 141-154.
15. Gao, Q., Reynolds, G.E., Innes, L., Pedram, M., Jones, E., Junabi, M., Gao, D.W., Ricoul, M., Sabatier, L., Van Brocklin, H. et al. (2007) Telomeric transgenes are silenced in adult mouse tissues and embryo fibroblasts but are expressed in embryonic stem cells. Stem Cells, 25, 3085-3092.
16. Argentaro, A., Yang, J.C., Chapman, L., Kowalczyk, M.S., Gibbons, R.J., Higgs, D.R., Neuhaus, D. and Rhodes, D. (2007) Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. Proc. Natl Acad. Sci. USA, 104, 11939-11944.
17. Gibbons, R.J., Bachoo, S., Picketts, D.J., Aftimos, S., Asenbauer, B., Bergoffen, J., Berry, S.A., Dahl, N., Fryer, A., Keppler, K. et al. (1997) Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat. Genet., 17, 146-148.
18. Gibbons, R.J., McDowell, T.L., Raman, S., O'Rourke, D.M., Garrick, D., Ayyub, H. and Higgs, D.R. (2000) Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet., 24, 368-371.
19. Loyola, A., Bonaldi, T., Roche, D., Imhof, A. and Almouzni, G. (2006) PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol. Cell, 24, 309-316.
20. Delbarre, E., Jacobsen, B.M., Reiner, A.H., Sorensen, A.L., Kuntziger, T. and Collas, P. (2010) Chromatin environment of histone variant H3.3 revealed by quantitative imaging and genome-scale chromatin and DNA immunoprecipitation. Mol. Biol. Cell, 21, 1872-1884.
21. Drane, P., Ouararhni, K., Depaux, A., Shuaib, M. and Hamiche, A. (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev., 24, 1253-1265.
22. Lewis, P.W., Elsaesser, S.J., Noh, K.M., Stadler, S.C. and Allis, C.D. (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl Acad. Sci. USA, 107, 14075-14080.
23. Goldberg, A.D., Banaszynski, L.A., Noh, K.M., Lewis, P.W., Elsaesser, S.J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X. et al. (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell, 140, 678-691.
24. Heaphy, C.M., de Wilde, R.F., Jiao, Y., Klein, A.P., Edil, B.H., Shi, C., Bettegowda, C., Rodriguez, F.J., Eberhart, C.G., Hebbar, S. et al. (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science, 333, 425.
25. Schwartzentruber, J., Korshunov, A., Liu, X.Y., Jones, D.T., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A.M., Quang, D.A., Tonjes, M. et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482, 226-231.
26. Wu, G., Broniscer, A., McEachron, T.A., Lu, C., Paugh, B.S., Becksfort, J., Qu, C., Ding, L., Huether, R., Parker, M. et al. (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet., 44, 251-253.
27. Heaphy, C.M., Subhawong, A.P., Hong, S.M., Goggins, M.G., Montgomery, E.A., Gabrielson, E., Netto, G.J., Epstein, J.I., Lotan, T.L., Westra, W.H. et al. (2011) Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am. J. Pathol., 179, 1608-1615.
28. Jiao, Y., Shi, C., Edil, B.H., de Wilde, R.F., Klimstra, D.S., Maitra, A., Schulick, R.D., Tang, L.H., Wolfgang, C.L., Choti, M.A. et al. (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science, 331, 1199-1203.
29. de Wilde, R.F., Heaphy, C.M., Maitra, A., Meeker, A.K., Edil, B.H., Wolfgang, C.L., Ellison, T.A., Schulick, R.D., Molenaar, I.Q., Valk, G.D. et al. (2012) Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod. Pathol., 25, 1033-1039.
30. Cheung, N.K., Zhang, J., Lu, C., Parker, M., Bahrami, A., Tickoo, S.K., Heguy, A., Pappo, A.S., Federico, S., Dalton, J. et al. (2012) Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA, 307, 1062-1071.
31. Capurso, G., Festa, S., Valente, R., Piciucchi, M., Panzuto, F., Jensen, R.T. and Delle Fave, G. (2012) Molecular pathology and genetics of pancreatic endocrine tumours. J. Mol. Endocrinol., 49, R37-R50.
32. Lovejoy, C.A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J.H., Sung, P.A., Jasin, M. et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet., 8, e1002772.
33. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P.P. et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature, 406, 207-210.
34. Salomoni, P. and Pandolfi, P.P. (2002) The role of PML in tumor suppression. Cell, 108, 165-170.
35. Bernardi, R. and Pandolfi, P.P. (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell. Biol., 8, 1006-1016.
36. Wu, G., Jiang, X., Lee, W.H. and Chen, P.L. (2003) Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res., 63, 2589-2595.
37. Jiang, W.Q., Zhong, Z.H., Henson, J.D., Neumann, A.A., Chang, A.C. and Reddel, R.R. (2005) Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell. Biol., 25, 2708-2721.
38. Jiang, W.Q., Zhong, Z.H., Henson, J.D. and Reddel, R.R. (2007) Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene, 26, 4635-4647.
39. Wu, G., Lee, W.H. and Chen, P.L. (2000) NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem., 275, 30618-30622.
40. Yu, J., Lan, J., Wang, C., Wu, Q., Zhu, Y., Lai, X., Sun, J., Jin, C. and Huang, H. (2011) PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells. Cancer Lett., 291, 177-186.
41. Torok, D., Ching, R.W. and Bazett-Jones, D.P. (2009) PML nuclear bodies as sites of epigenetic regulation. Front. Biosci., 14, 1325-1336.
42. Ching, R.W., Dellaire, G., Eskiw, C.H. and Bazett-Jones, D.P. (2005) PML bodies: a meeting place for genomic loci? J. Cell Sci., 118, 847-854.
43. Wong, L.H., Brettingham-Moore, K.H., Chan, L., Quach, J.M., Anderson, M.A., Northrop, E.L., Hannan, R., Saffery, R., Shaw, M.L., Williams, E. et al. (2007) Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere. Genome Res., 17, 1146-1160.
44. Iwano, T., Tachibana, M., Reth, M. and Shinkai, Y. (2004) Importance of TRF1 for functional telomere structure. J. Biol. Chem., 279, 1442-1448.
45. Newhart, A., Rafalska-Metcalf, I.U., Yang, T., Negorev, D.G. and Janicki, S.M. (2012) Single cell analysis of Daxx and ATRXdependent transcriptional repression. J. Cell Sci., 125(Pt 22), 5489-5501.
46. Xue, Y., Gibbons, R., Yan, Z., Yang, D., McDowell, T.L., Sechi, S., Qin, J., Zhou, S., Higgs, D. and Wang, W. (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc. Natl Acad. Sci. USA, 100, 10635-10640.
47. Ishov, A.M., Vladimirova, O.V. and Maul, G.G. (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J. Cell Sci., 117, 3807-3820.
48. Dellaire, G., Ching, R.W., Ahmed, K., Jalali, F., Tse, K.C., Bristow, R.G. and Bazett-Jones, D.P. (2006) Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J. Cell Biol., 175, 55-66.
49. Verdun, R.E. and Karlseder, J. (2007) Replication and protection of telomeres. Nature, 447, 924-931.
50. Hockemeyer, D., Sfeir, A.J., Shay, J.W., Wright, W.E. and de Lange, T. (2005) POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J., 24, 2667-2678.
51. Pickett, H.A., Cesare, A.J., Johnston, R.L., Neumann, A.A. and Reddel, R.R. (2009) Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J., 28, 799-809.
52. Shiels, C., Islam, S.A., Vatcheva, R., Sasieni, P., Sternberg, M.J., Freemont, P.S. and Sheer, D. (2001) PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci., 114, 3705-3716.
53. Ng, L.J., Cropley, J.E., Pickett, H.A., Reddel, R.R. and Suter, C.M. (2009) Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res., 37, 1152-1159.
54. Hansen, R.S., Wijmenga, C., Luo, P., Stanek, A.M., Canfield, T.K., Weemaes, C.M. and Gartler, S.M. (1999) The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA, 96, 14412-14417.
55. Luciani, J.J., Depetris, D., Usson, Y., Metzler-Guillemain, C., Mignon-Ravix, C., Mitchell, M.J., Megarbane, A., Sarda, P., Sirma, H., Moncla, A. et al. (2006) PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J. Cell Sci., 119, 2518-2531.
56. Deng, Z., Norseen, J., Wiedmer, A., Riethman, H. and Lieberman, P.M. (2009) TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell, 35, 403-413.